Gilead Sciences Announces Declaration of Q1 Cash Dividend and Increases to Shareholder Return Programs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Japanese Hep C Boosts Gilead Sciences (GILD) in the Qtr - Baird
February 3, 2016 7:20 AM ESTBaird analyst Brian Skorney reiterated an Outperform rating and $135 price target on Gilead Sciences (NASDAQ: GILD) following Q4 results which beat on Japanese Hep C.
Skorney commented, "Gilead delivered another top- and bottom-line beat, driven by Japanese Hep C sales. We... More
Gilead's (GILD) Increased Unit Sales Tempered By Lower Prices - Oppenheimer
February 3, 2016 7:11 AM ESTOppenheimer analyst, Wendy Lam, trimmed her price target on Gilead Sciences (NASDAQ: GILD) as the increasing volume of Harvoni will be offset by reductions in price. One bright note was the strong start to HIV as Genvoya generated $44B in sales. PT is cut to $120 from $124 but maintaining the Outperform rating.
GILD reported 4Q15 revenue of $8.5B and non-GAAP EPS of $3.32, topping Street consensus estimates of $8.2B and $3.00. However, GILD's 2016 guidance on net product sales of... More
Gilead Sciences (GILD) Declares $0.43 Quarterly Dividend; Adds $12B to Stock Buyback Plan
February 2, 2016 4:03 PM ESTGilead Sciences (NASDAQ: GILD) declared a quarterly dividend of $0.43 per share, or $1.72 annualized.
The dividend will be payable on March 30, 2016, to stockholders of record on March 16, 2016, with an ex-dividend date of March 14, 2016.
The annual yield on the dividend is 2.1 percent.
In addition the Board authorized an increase of 4 cents (ten percent) in the companys quarterly dividend program,... More
Gilead Sciences (GILD) Declares $0.43 Quarterly Dividend; Adds $12B to Stock Buyback Plan
February 2, 2016 4:03 PM ESTGilead Sciences (NASDAQ: GILD) declared a quarterly dividend of $0.43 per share, or $1.72 annualized.
The dividend will be payable on March 30, 2016, to stockholders of record on March 16, 2016, with an ex-dividend date of March 14, 2016.
The annual yield on the dividend is 2.1 percent.
In addition the Board authorized an increase of 4 cents (ten percent) in the companys quarterly dividend program,... More
